Ranjita Shegokar

4.7k total citations · 2 hit papers
42 papers, 3.4k citations indexed

About

Ranjita Shegokar is a scholar working on Pharmaceutical Science, Molecular Biology and Food Science. According to data from OpenAlex, Ranjita Shegokar has authored 42 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmaceutical Science, 15 papers in Molecular Biology and 6 papers in Food Science. Recurrent topics in Ranjita Shegokar's work include Drug Solubulity and Delivery Systems (15 papers), Advancements in Transdermal Drug Delivery (13 papers) and Advanced Drug Delivery Systems (10 papers). Ranjita Shegokar is often cited by papers focused on Drug Solubulity and Delivery Systems (15 papers), Advancements in Transdermal Drug Delivery (13 papers) and Advanced Drug Delivery Systems (10 papers). Ranjita Shegokar collaborates with scholars based in Germany, India and Italy. Ranjita Shegokar's co-authors include Rainer Müller, Anisha D’Souza, Khalil Mitri, Cornelia M. Keck, Kamalinder K. Singh, Sven Gohla, Cecilia Anselmi, Loaye Al Shaal, Nanda Gopal Sahoo and Lin Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, British Journal of Pharmacology and International Journal of Pharmaceutics.

In The Last Decade

Ranjita Shegokar

41 papers receiving 3.3k citations

Hit Papers

Polyethylene glycol (PEG): a versatile polymer for pha... 2010 2026 2015 2020 2016 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ranjita Shegokar Germany 23 1.5k 875 760 496 491 42 3.4k
Maurizio Ricci Italy 40 1.8k 1.2× 1.2k 1.4× 1.1k 1.5× 636 1.3× 654 1.3× 179 5.1k
Sepideh Khorasani Iran 8 946 0.6× 1.0k 1.2× 908 1.2× 624 1.3× 506 1.0× 15 3.7k
Mangal S. Nagarsenker India 33 2.1k 1.4× 1.0k 1.2× 691 0.9× 469 0.9× 379 0.8× 84 3.9k
Abbas Pardakhty Iran 38 1.1k 0.7× 1.6k 1.8× 678 0.9× 424 0.9× 582 1.2× 143 4.5k
Shahla Ataei Iran 11 914 0.6× 934 1.1× 962 1.3× 508 1.0× 644 1.3× 21 3.8k
Marina Gallarate Italy 32 1.7k 1.1× 1.2k 1.4× 795 1.0× 478 1.0× 252 0.5× 97 3.5k
Maria Carafa Italy 37 1.5k 1.0× 1.4k 1.6× 739 1.0× 513 1.0× 287 0.6× 115 3.6k
Hira Choudhury Malaysia 44 1.5k 1.0× 1.3k 1.5× 1.3k 1.6× 362 0.7× 532 1.1× 100 5.2k
Ibrahim A. Alsarra Saudi Arabia 39 1.6k 1.1× 697 0.8× 720 0.9× 467 0.9× 1.1k 2.3× 163 4.4k
Rita Muzzalupo Italy 35 1.5k 1.0× 876 1.0× 695 0.9× 389 0.8× 272 0.6× 97 3.4k

Countries citing papers authored by Ranjita Shegokar

Since Specialization
Citations

This map shows the geographic impact of Ranjita Shegokar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjita Shegokar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjita Shegokar more than expected).

Fields of papers citing papers by Ranjita Shegokar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ranjita Shegokar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjita Shegokar. The network helps show where Ranjita Shegokar may publish in the future.

Co-authorship network of co-authors of Ranjita Shegokar

This figure shows the co-authorship network connecting the top 25 collaborators of Ranjita Shegokar. A scholar is included among the top collaborators of Ranjita Shegokar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ranjita Shegokar. Ranjita Shegokar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shegokar, Ranjita & Yashwant Pathak. (2023). Tubercular Drug Delivery Systems. 3 indexed citations
2.
Shegokar, Ranjita & Yashwant Pathak. (2023). Malarial Drug Delivery Systems. 2 indexed citations
3.
Weinreich, Frank‐Jürgen, et al.. (2021). Experimental evaluation of icodextrin delivery as pressurized aerosol (PIPAC): Antiadhesive and cytotoxic effects. European Journal of Surgical Oncology. 47(6). 1434–1440. 2 indexed citations
4.
D’Souza, Anisha & Ranjita Shegokar. (2020). Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil). Current Drug Delivery. 18(3). 249–270. 30 indexed citations
5.
Nakach, Mostafa, Ranjita Shegokar, Jean‐René Authelin, & Tharwat F. Tadros. (2018). Nano-crystalline Suspensions by Top Down Processes: Review of Manufacturing Considerations. Drug Delivery Letters. 8(3). 184–199. 3 indexed citations
6.
Shegokar, Ranjita, et al.. (2017). Nanoformulation of Leonotis leonurus to improve its bioavailability as a potential antidiabetic drug. 3 Biotech. 7(5). 344–344. 11 indexed citations
7.
Rai, Mahendra & Ranjita Shegokar. (2017). Metal Nanoparticles in Pharma. DIAL (Catholic University of Leuven). 43 indexed citations
8.
Shegokar, Ranjita & Khalil Mitri. (2012). Carotenoid Lutein: A Promising Candidate for Pharmaceutical and Nutraceutical Applications. Journal of Dietary Supplements. 9(3). 183–210. 60 indexed citations
9.
Shegokar, Ranjita & Kamalinder K. Singh. (2012). Nevirapine nanosuspensions: stability, plasma compatibility and sterilization. Journal of Pharmaceutical Investigation. 42(5). 257–269. 7 indexed citations
10.
Shegokar, Ranjita & Kamalinder K. Singh. (2012). Preparation, Characterization and Cell Based Delivery of Stavudine Surface Modified Lipid Nanoparticles. 1(S1). 1 indexed citations
11.
Shegokar, Ranjita & Kamalinder K. Singh. (2012). IN VIVO EVALUATION OF SUPPOCIRE PARACETAMOL RECTAL SUPPOSITORIES. CLOK (University of Central Lancashire).
12.
Shegokar, Ranjita & Kamalinder K. Singh. (2011). Conversion of stavudine lipid nanoparticles into dry powder. International Journal of Pharma and Bio Sciences. 7 indexed citations
13.
Kakran, Mitali, Ranjita Shegokar, Nanda Gopal Sahoo, et al.. (2011). Fabrication of quercetin nanocrystals: Comparison of different methods. European Journal of Pharmaceutics and Biopharmaceutics. 80(1). 113–121. 119 indexed citations
14.
Shegokar, Ranjita & Kamalinder K. Singh. (2011). Stavudine entrapped lipid nanoparticles for targeting lymphatic HIV reservoirs.. PubMed. 66(4). 264–71. 16 indexed citations
15.
Shaal, Loaye Al, Ranjita Shegokar, & Rainer Müller. (2011). Production and characterization of antioxidant apigenin nanocrystals as a novel UV skin protective formulation. International Journal of Pharmaceutics. 420(1). 133–140. 104 indexed citations
16.
Mitri, Khalil, Ranjita Shegokar, Sven Gohla, Cecilia Anselmi, & Rainer Müller. (2011). Lutein nanocrystals as antioxidant formulation for oral and dermal delivery. International Journal of Pharmaceutics. 420(1). 141–146. 125 indexed citations
17.
Müller, Rainer, Ranjita Shegokar, & Cornelia M. Keck. (2011). 20 Years of Lipid Nanoparticles (SLN & NLC): Present State of Development & Industrial Applications. Current Drug Discovery Technologies. 8(3). 207–227. 413 indexed citations
18.
Shegokar, Ranjita, et al.. (2010). Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex. Drug Development and Industrial Pharmacy. 37(4). 396–407. 30 indexed citations
19.
Shegokar, Ranjita, et al.. (2010). In vitro protein adsorption studies on nevirapine nanosuspensions for HIV/AIDS chemotherapy. Nanomedicine Nanotechnology Biology and Medicine. 7(3). 333–340. 31 indexed citations
20.
Shegokar, Ranjita, Kamalinder K. Singh, & Rainer Müller. (2010). Production & stability of stavudine solid lipid nanoparticles—From lab to industrial scale. International Journal of Pharmaceutics. 416(2). 461–470. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026